Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma

International Journal of Cancer

Volumn 129, Issue 6, 2011, Pages 1382-1390

  Lin, Aifen ^a   Zhang, Xia ^a   Zhou, Wen Jun ^a   Ruan, Yan Yun ^a   Xu, Dan Ping ^a   Wang, Qing ^a   Yan, Wei Hua ^a  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

esophageal carcinoma; HLA G; prognosis; soluble HLA G

Indexed keywords

HLA G ANTIGEN;

ADULT; ANTIGEN EXPRESSION; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RECEIVER OPERATING CHARACTERISTIC; TISSUE DISTRIBUTION;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 79960896620     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25807     Document Type: Article

References (50)

1. Reiman JM, Kmieciak M, Manjili MH, Knutson KL,. Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol 2007; 17: 275-87. (Pubitemid 47211962)
2. Ferrone S, Whiteside TL,. Tumor microenvironment and immune escape. Surg Oncol Clin N Am 2007; 16: 755-74. (Pubitemid 350101281)
3. Waldhauer I, Steinle A,. NK cells and cancer immunosurveillance. Oncogene 2008; 27: 5932-43.
4. Gomes AQ, Correia DV, Silva-Santos B,. Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance. EMBO Rep 2007; 8: 1024-30. (Pubitemid 350042337)
5. Ibrahim EC, Aractingi S, Allory Y, Borrini F, Dupuy A, Duvillard P, Carosella ED, Avril MF, Paul P,. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype. Int J Cancer 2004; 108: 243-50. (Pubitemid 37541778)
6. Ibrahim EC, Allory Y, Commo F, Gattegno B, Callard P, Paul P,. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma. Am J Pathol 2003; 162: 501-8. (Pubitemid 36267857)
7. Hviid TV,. HLA-G in human reproduction, aspects of genetics; function and pregnancy complications. Hum Reprod Update 2006; 12: 209-32.
8. Park B, Lee S, Kim E, Chang S, Jin M, Ahn K,. The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments. Immunity 2001; 15: 213-24. (Pubitemid 32816871)
9. LeMaoult J, Le Discorde M, Rouas-Freiss N, Moreau P, Menier C, McCluskey J, Carosella ED,. Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 2003; 62: 273-84. (Pubitemid 37204582)
10. Münz C, Nickolaus P, Lammert E, Pascolo S, Stevanovic S, Rammensee HG,. The role of peptide presentation in the physiological function of HLA-G. Semin Cancer Biol 1999; 9: 47-54. (Pubitemid 29178543)
11. Rouas-Freiss N, Moreau P, Menier C, Carosella ED,. HLA-G in cancer, a way to turn off the immune system. Semin Cancer Biol 2003; 13: 325-36. (Pubitemid 38160931)
12. Paul P, Cabestre FA, Ibrahim EC, Lefebvre S, Khalil-Daher I, Vazeux G, Quiles RM, Bermond F, Dausset J, Carosella ED,. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 2000; 61: 1138-49. (Pubitemid 32043892)
13. Park GM, Lee S, Park B, Kim E, Shin J, Cho K, Ahn K,. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem Biophys Res Commun 2004; 313: 606-11. (Pubitemid 38021873)
14. Lin A, Yan WH, Xu HH, Gan MF, Cai JF, Zhu M, Zhou MY,. HLA-G expression in human ovarian carcinoma counteracts NK cell function. Ann Oncol 2007; 18: 1804-9.
15. Lin A, Zhu CC, Chen HX, Chen BF, Zhang X, Zhang JG, Wang Q, Zhou WJ, Hu W, Yang HH, Xu HH, Yan WH,. Clinical relevance and functional implications for human leukocyte antigen-G expression in non-small-cell lung cancer. J Cell Mol Med 2010; 14: 2318-29.
16. Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet JG, Carosella ED, Rouas-Freiss N,. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 1999; 11: 1351-6. (Pubitemid 29355674)
17. + cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003; 33: 125-34. (Pubitemid 36157650)
18. + cells by interacting with CD8. J Immunol 2000; 164: 6100-4. (Pubitemid 30408785)
19. Bainbridge DR, Ellis SA, Sargent IL,. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol 2000; 48: 17-26.
20. + T cell regulatory mechanism. Proc Natl Acad Sci USA 2001; 98: 12150-5. (Pubitemid 32959842)
21. Liang S, Horuzsko A,. Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. Hum Immunol 2003; 64: 1025-32. (Pubitemid 37413710)
22. Gregori S, Magnani CF, Roncarolo MG,. Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells. Hum Immunol 2009; 70: 966-9.
23. Urosevic M, Dummer R,. Human leukocyte antigen-G and cancer immunoediting. Cancer Res 2008; 68: 627-30. (Pubitemid 351206734)
24. Lin A, Chen HX, Zhu CC, Zhang X, Xu HH, Zhang JG, Wang Q, Zhou WJ, Yan WH,. Aberrant human leukocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma. J Cell Mol Med 2010; 14: 2162-71.
25. Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li YW, Zhang BH, Zhou J, Fan J,. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin Cancer Res 2009; 15: 4686-93.
26. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM,. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer 2007; 58: 267-74. (Pubitemid 47516690)
27. Schütt P, Schütt B, Switala M, Bauer S, Stamatis G, Opalka B, Eberhardt W, Schuler M, Horn PA, Rebmann V,. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients. Hum Immunol 2010; 71: 489-95.
28. He X, Dong DD, Yie SM, Yang H, Cao M, Ye SR, Li K, Liu J, Chen J,. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro. Ann Surg Oncol 2010; 17: 1459-69.
29. Bijen CB, Bantema-Joppe EJ, de Jong RA, Leffers N, Mourits MJ, Eggink HF, van der Zee AG, Hollema H, de Bock GH, Nijman HW,. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer. Int J Cancer 2010; 126: 1417-27.
30. Nückel H, Rebmann V, Dürig J, Dührsen U, Grosse-Wilde H,. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 2005; 105: 1694-8. (Pubitemid 40223692)
31. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM,. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol 2007; 14: 2721-9. (Pubitemid 47460633)
32. Ye SR, Yang H, Li K, Dong DD, Lin XM, Yie SM,. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol 2007; 20: 375-83. (Pubitemid 46348337)
33. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
34. Mizukami Y, Kono K, Maruyama T, Watanabe M, Kawaguchi Y, Kamimura K, Fujii H,. Downregulation of HLA class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. Br J Cancer 2008; 99: 1462-7.
35. Liu Q, Hao C, Su P, Shi J,. Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression. Scand J Gastroenterol 2009; 44: 960-9.
36. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM,. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol 2007; 128: 1002-9.
37. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors, 6th edn. New York, NY: Wiley-Liss, 2002. 81-3.
38. Carosella ED, HoWangYin KY, Favier B, LeMaoult J,. HLA-G-dependent suppressor cells: diverse by nature, function, and significance. Hum Immunol 2008; 69: 700-7.
39. Hansel DE, Rahman A, Wilentz RE, Shih IeM, McMaster MT, Yeo CJ, Maitra A,. HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract. Int J Gastrointest Cancer 2005; 35: 15-23. (Pubitemid 40458576)
40. Ishigami S, Natsugoe S, Miyazono F, Nakajo A, Tokuda K, Matsumoto M, Okumura H, Douchi T, Hokita S, Aikou T,. HLA-G expression in gastric cancer. Anticancer Res 2006; 26: 2467-72. (Pubitemid 43980219)
41. Urosevic M, Kurrer MO, Kamarashev J, Mueller B, Weder W, Burg G, Stahel RA, Dummer R, Trojan A,. Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 2001; 159: 817-24. (Pubitemid 32847172)
42. Paul P, Rouas-Freiss N, Moreau P, Cabestre FA, Menier C, Khalil-Daher I, Pangault C, Onno M, Fauchet R, Martinez-Laso J, Morales P, Villena AA, et al. HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum Immunol 2000; 61: 1177-95. (Pubitemid 32043896)
43. Morandi F, Levreri I, Bocca P, Galleni B, Raffaghello L, Ferrone S, Prigione I, Pistoia V,. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release. Cancer Res 2007; 67: 6433-41. (Pubitemid 47037528)
44. Li BL, Lin A, Zhang XJ, Zhang X, Zhang JG, Wang Q, Zhou WJ, Chen HX, Wang TJ, Yan WH,. Characterization of HLA-G expression in renal cell carcinoma. Tissue Antigens 2009; 74: 213-21.
45. Singer G, Rebmann V, Chen YC, Liu HT, Ali SZ, Reinsberg J, McMaster MT, Pfeiffer K, Chan DW, Wardelmann E, Grosse-Wilde H, Cheng CC, et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 2003; 9: 4460-4. (Pubitemid 37248404)
46. Gan LH, Huang LF, Zhang X, Lin A, Xu DP, Wang Q, Wang TJ, Yan WH,. Tumor-specific up-regulation of HLA-G expression in bladder transitional cell carcinoma. Hum Immunol 2010; 71: 899-904.
47. Chen HX, Lin A, Shen CJ, Zhen R, Chen BG, Zhang X, Cao FL, Zhang JG, Yan WH,. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer. Hum Immunol 2010; 71: 892-8.
48. Zhu CB, Wang CX, Zhang X, Zhang J, Li W,. Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases. Int J Cancer 2011; 128: 617-22.
49. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N,. HLA-G: from biology to clinical benefits. Trends Immunol 2008; 29: 125-32.
50. Leleu X, Le Friec G, Facon T, Amiot L, Fauchet R, Hennache B, Coiteux V, Yakoub-Agha I, Dubucquoi S, Avet-Loiseau H, Mathiot C, Bataille R, et al. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance. Clin Cancer Res 2005; 11: 7297-303. (Pubitemid 41507687)